{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:04:07Z","timestamp":1785769447455,"version":"3.56.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jcyt.2018.11.001","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T23:47:54Z","timestamp":1553298474000},"page":"315-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characterization of human natural killer cells for therapeutic use"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-8259","authenticated-orcid":false,"given":"ARNIKA K.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5307-6648","authenticated-orcid":false,"given":"EVREN","family":"ALICI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARK W.","family":"LOWDELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcyt.2018.11.001_bib0001","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/eji.1830050209","article-title":"\u201cNatural\u201d killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.001_bib0002","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/eji.1830050208","article-title":"\u201cNatural\u201d killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.001_bib0003","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ijc.2910160205","article-title":"Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells","volume":"16","author":"Herberman","year":"1975","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.001_bib0004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ijc.2910160204","article-title":"Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity","volume":"16","author":"Herberman","year":"1975","journal-title":"Int J Cancer"},{"issue":"23","key":"10.1016\/j.jcyt.2018.11.001_bib0005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","article-title":"Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer","volume":"313","author":"Rosenberg","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0006","first-page":"159","article-title":"Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenos leukemia","volume":"12","author":"Benyunes","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0007","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horwitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0008","doi-asserted-by":"crossref","first-page":"20414","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0009","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.coviro.2011.10.017","article-title":"Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience","volume":"1","author":"Vidal","year":"2011","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0952-7915(97)80155-0","article-title":"Activation and function of natural killer cell responses during viral infections","volume":"9","author":"Biron","year":"1997","journal-title":"Curr Opin Immunol"},{"issue":"6475","key":"10.1016\/j.jcyt.2018.11.001_bib0011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/369031a0","article-title":"Cytotoxicity mediated by T-cells and natural-killer-cells is greatly impaired in perforin deficient mice","volume":"369","author":"Kagi","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.001_bib0012","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","article-title":"Activation of NK cell cytotoxicity","volume":"42","author":"Smyth","year":"2005","journal-title":"Mol Immunol"},{"issue":"11","key":"10.1016\/j.jcyt.2018.11.001_bib0013","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.4049\/jimmunol.162.11.6658","article-title":"Perforin is a major contributor to NK cell control of tumor metastasis","volume":"162","author":"Smyth","year":"1999","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.001_bib0014","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1084\/jem.188.12.2375","article-title":"Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells","volume":"188","author":"Zamai","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/B978-0-12-800147-9.00003-0","article-title":"How immunoglobulin G antibodies kill target cells: revisiting an old paradigm","volume":"124","author":"Biburger","year":"2014","journal-title":"Adv Immunol"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.001_bib0016","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.141.10.3478","article-title":"Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes","volume":"141","author":"Lanier","year":"1988","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.jcyt.2018.11.001_bib0017","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.20030630","article-title":"Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function","volume":"198","author":"Stetson","year":"2003","journal-title":"J Exp Med"},{"issue":"6013","key":"10.1016\/j.jcyt.2018.11.001_bib0018","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0019","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.immunol.19.1.291","article-title":"Regulation of the natural killer cell receptor repertoire","volume":"19","author":"Raulet","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0021","first-page":"95","article-title":"Dynamic regulation of NK cell responsiveness","volume":"395","author":"Kadri","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0022","first-page":"63","article-title":"Diversification and functional specialization of human NK cell subsets","volume":"395","author":"Cichicki","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0023","first-page":"147","article-title":"Sweet Is the Memory of Past Troubles: NK Cells Remember","volume":"395","author":"Hendricks","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.001_bib0024","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000326891","article-title":"Natural killer cell activation secondary to innate pattern sensing","volume":"3","author":"Seya","year":"2011","journal-title":"J Innate Immun"},{"issue":"6055","key":"10.1016\/j.jcyt.2018.11.001_bib0026","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy","volume":"319","author":"K\u00e4rre","year":"1986","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jcyt.2018.11.001_bib0027","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u2018missing self': MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"issue":"7","key":"10.1016\/j.jcyt.2018.11.001_bib0028","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4049\/jimmunol.145.7.2353","article-title":"Chromosomal location of the Ly-49 (A1, YE1\/48) multigene family. Genetic association with the NK 1.1 antigen","volume":"145","author":"Yokoyama","year":"1990","journal-title":"J Immunol"},{"issue":"5209","key":"10.1016\/j.jcyt.2018.11.001_bib0029","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.7716543","article-title":"Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells","volume":"268","author":"Colonna","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"10.1016\/j.jcyt.2018.11.001_bib0031","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0167-5699(00)01673-X","article-title":"Human NK-cell receptors","volume":"21","author":"Moretta","year":"2000","journal-title":"Immunol Today"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.001_bib0032","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1084\/jem.188.10.1841","article-title":"Mouse CD94\/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)","volume":"188","author":"Vance","year":"1998","journal-title":"J Exp Med"},{"issue":"6669","key":"10.1016\/j.jcyt.2018.11.001_bib0033","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.001_bib0034","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.187.5.813","article-title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94\/NKG2 confers protection from natural killer cell-mediated lysis","volume":"187","author":"Borrego","year":"1998","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.001_bib0035","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4409::AID-IMMU4409>3.0.CO;2-3","article-title":"2F1 antigen, the mouse homolog of the rat \u201cmast cell function-associated antigen\u201d, is a lectin-like type II transmembrane receptor expressed by natural killer cells","volume":"28","author":"Hanke","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0036","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.4049\/jimmunol.156.8.2866","article-title":"A carbohydrate structure associated with CD15 (Lewisx) on myeloid cells is a novel ligand for human CD2","volume":"156","author":"Warren","year":"1996","journal-title":"J.Immunol."},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.001_bib0037","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/ijc.2910530524","article-title":"Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures","volume":"53","author":"Maenpaa","year":"1993","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0038","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2567.1996.d01-706.x","article-title":"Expression and function of alpha 4\/beta 7 integrin on human natural killer cells","volume":"89","author":"Perez-Villar","year":"1996","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0039","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.161.1.400","article-title":"Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets","volume":"161","author":"Frey","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.001_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0041","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.4049\/jimmunol.173.6.3653","article-title":"LFA-1 contributes an early signal for NK cell cytotoxicity","volume":"173","author":"Barber","year":"2004","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.001_bib0042","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1074-7613(00)80136-3","article-title":"Physical and functional association of LFA-1 with DNAM-1 adhesion molecule","volume":"11","author":"Shibuya","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0043","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3389\/fimmu.2018.02159","article-title":"The role of CXC chemokine receptors 1\u20134 on immune cells in the tumor microenvironment","volume":"9","author":"Susek","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.001_bib0044","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ni.1953","article-title":"Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses","volume":"11","author":"Paust","year":"2010","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2018.11.001_bib0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni1332","article-title":"T cell- and B cell-independent adaptive immunity mediated by natural killer cells","volume":"7","author":"O'Leary","year":"2006","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0046","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-induced memory-like natural killer cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7229","key":"10.1016\/j.jcyt.2018.11.001_bib0047","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0048","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0049","first-page":"225","article-title":"The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer","volume":"395","author":"Cichocki","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0050","article-title":"Diversification and Functional Specialization of Human NK Cell Subsets","author":"Cichocki","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.001_bib0051","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Guma","year":"2004","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jcyt.2018.11.001_bib0052","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"Beziat","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.001_bib0053","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.1201964","article-title":"Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen","volume":"189","author":"Foley","year":"2012","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0054","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1084\/jem.164.3.814","article-title":"Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis","volume":"164","author":"Phillips","year":"1986","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0055","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood.V67.3.722.722","article-title":"Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation","volume":"67","author":"Hercend","year":"1986","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.001_bib0056","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00262-008-0492-7","article-title":"NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy","volume":"57","author":"Malmberg","year":"2008","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.001_bib0057","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.molimm.2004.07.037","article-title":"KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation","volume":"42","author":"Malmberg","year":"2005","journal-title":"Mol Immunol"},{"issue":"8","key":"10.1016\/j.jcyt.2018.11.001_bib0058","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0059","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"issue":"5562","key":"10.1016\/j.jcyt.2018.11.001_bib0060","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.001_bib0061","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0062","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood-2008-07-171926","article-title":"Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia","volume":"113","author":"Cooley","year":"2009","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jcyt.2018.11.001_bib0063","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.001_bib0064","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.4049\/jimmunol.1302517","article-title":"Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia","volume":"192","author":"Cooley","year":"2014","journal-title":"J Immunol"},{"issue":"23","key":"10.1016\/j.jcyt.2018.11.001_bib0065","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1158\/1078-0432.CCR-09-1720","article-title":"KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma","volume":"15","author":"Venstrom","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.jcyt.2018.11.001_bib0066","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.1202120","article-title":"NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand","volume":"190","author":"Pittari","year":"2013","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.001_bib0067","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-3046.2010.01447.x","article-title":"KIR\/HLA-I mismatching and risk of relapse in paediatric patients undergoing non-haploidentical allogeneic haematopoietic stem cell transplantation","volume":"15","author":"Scquizzato","year":"2011","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2018.11.001_bib0068","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/1078-0432.CCR-17-3196","article-title":"Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML","volume":"24","author":"Bjorklund","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123416","article-title":"Two-stage priming of allogeneic Natural Killer cells for the treatment of patients with acute myeloid leukemia; a phase I trial","volume":"10","author":"Kottaridis","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.001_bib0070","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1115178","article-title":"Advances in clinical NK cell studies: Donor selection, manufacturing and quality control","volume":"5","author":"Koehl","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0071","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fimmu.2015.00605","article-title":"Natural killer cell-based therapies targeting cancer: possible strategies to gain and sustain anti-tumor activity","volume":"6","author":"Dahlberg","year":"2015","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.001_bib0072","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2796.2009.02121.x","article-title":"Natural killer cell-based immunotherapy in cancer: current insights and future prospects","volume":"266","author":"Sutlu","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0073","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fimmu.2013.00408","article-title":"Tumor-primed NK cells: waiting for the green light","volume":"4","author":"Sabry","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0074","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-1-4939-3684-7_29","article-title":"Regulatory Considerations for NK cells used in human immunotherapy applications","volume":"1441","author":"Lee","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-1759(01)00336-2","article-title":"Development of a novel flow cytometric cell-mediated cytotoxicity assay using fluorophores PKH-26 and TO-PRO-3 iodide","volume":"252","author":"Lee-MacAry","year":"2001","journal-title":"J. Immunol. Methods"},{"issue":"1-2","key":"10.1016\/j.jcyt.2018.11.001_bib0076","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0077","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1189\/jlb.0306191","article-title":"Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells","volume":"80","author":"Wendt","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"11","key":"10.1016\/j.jcyt.2018.11.001_bib0078","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0079","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jcyt.2018.11.001_bib0080","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0081","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1038\/s41598-017-06238-4","article-title":"CD56 is a pathogen recognition receptor on human natural killer cells","volume":"7","author":"Ziegler","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0082","doi-asserted-by":"crossref","first-page":"12171","DOI":"10.1038\/ncomms12171","article-title":"Human NK cell development requires CD56-mediated motility and formation of the developmental synapse","volume":"7","author":"Mace","year":"2016","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0083","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4049\/jimmunol.178.1.85","article-title":"Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation","volume":"178","author":"North","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jcyt.2018.11.001_bib0084","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.4049\/jimmunol.147.10.3459","article-title":"Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II)","volume":"147","author":"Harrison","year":"1991","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10428190500272549","article-title":"Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant","volume":"47","author":"Chang","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0086","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jcyt.2018.11.001_bib0087","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1200\/JCO.2006.08.8021","article-title":"FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab","volume":"25","author":"Zhang","year":"2007","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jcyt.2018.11.001_bib0088","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1200\/JCO.2007.14.8957","article-title":"Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2\/neu-positive metastatic breast cancer","volume":"26","author":"Musolino","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jcyt.2018.11.001_bib0089","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2008.18.0463","article-title":"Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan","volume":"27","author":"Bibeau","year":"2009","journal-title":"J Clin Oncol"},{"issue":"52","key":"10.1016\/j.jcyt.2018.11.001_bib0090","doi-asserted-by":"crossref","first-page":"86359","DOI":"10.18632\/oncotarget.13411","article-title":"An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele","volume":"7","author":"Jochems","year":"2016","journal-title":"Oncotarget"},{"issue":"21","key":"10.1016\/j.jcyt.2018.11.001_bib0091","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V118.21.2184.2184","article-title":"ADAM17, a novel metalloproteinase, mediates CD16 and CD62L shedding in human NK cells and modulates IFN\u03b3 responses","volume":"118","author":"Romee","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0092","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121788","article-title":"Identification of an ADAM17 cleavage region in human CD16 (FcgammaRIII) and the engineering of a non-cleavable version of the receptor in NK cells","volume":"10","author":"Jing","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jcyt.2018.11.001_bib0093","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1083\/jcb.201712085","article-title":"Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells","volume":"217","author":"Srpan","year":"2018","journal-title":"The Journal of Cell Biology"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0094","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood-2007-09-110312","article-title":"Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components","volume":"111","author":"Alici","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-2005-872520","article-title":"Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children","volume":"217","author":"Koehl","year":"2005","journal-title":"Klin Padiatr"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.001_bib0096","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ajh.22163","article-title":"Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells","volume":"86","author":"Katodritou","year":"2011","journal-title":"Am J Hematol"},{"issue":"7054","key":"10.1016\/j.jcyt.2018.11.001_bib0097","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"issue":"6852","key":"10.1016\/j.jcyt.2018.11.001_bib0098","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","article-title":"Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0099","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1074-7613(00)80222-8","article-title":"Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice","volume":"12","author":"Cerwenka","year":"2000","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.jcyt.2018.11.001_bib0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D Receptor and Its Ligands in Host Defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0101","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/icb.2013.98","article-title":"Natural cytotoxicity receptors and their ligands","volume":"92","author":"Kruse","year":"2014","journal-title":"Immunol Cell Biol"},{"issue":"9","key":"10.1016\/j.jcyt.2018.11.001_bib0102","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.4049\/jimmunol.177.9.6192","article-title":"Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor","volume":"177","author":"Garg","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2018.11.001_bib0103","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.20011149","article-title":"Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells","volume":"195","author":"Ferlazzo","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fimmu.2015.00031","article-title":"NKp44 and natural cytotoxicity receptors as damage-associated molecular pattern recognition receptors","volume":"6","author":"Horton","year":"2015","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jcyt.2018.11.001_bib0105","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A","article-title":"Recognition of viral hemagglutinins by NKp44 but not by NKp30","volume":"31","author":"Arnon","year":"2001","journal-title":"Eur J Immunol"},{"issue":"6823","key":"10.1016\/j.jcyt.2018.11.001_bib0106","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells","volume":"409","author":"Mandelboim","year":"2001","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jcyt.2018.11.001_bib0107","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1084\/jem.20030958","article-title":"CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation","volume":"198","author":"Shibuya","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0108","doi-asserted-by":"crossref","first-page":"15627","DOI":"10.1038\/ncomms15627","article-title":"Expression of CD226 is associated to but not required for NK cell education","volume":"8","author":"Wagner","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jcyt.2018.11.001_bib0109","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.4049\/jimmunol.1401972","article-title":"Coordinated expression of DNAM-1 and LFA-1 in educated NK cells","volume":"194","author":"Enqvist","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1189\/jlb.1208745","article-title":"Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells","volume":"86","author":"Seth","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.jcyt.2018.11.001_bib0111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.celrep.2015.03.006","article-title":"DNAM-1 expression marks an alternative program of NK cell maturation","volume":"11","author":"Martinet","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2013.12.011","article-title":"Costimulatory Molecule DNAM-1 Is Essential for Optimal Differentiation of Memory Natural Killer Cells during Mouse Cytomegalovirus Infection","author":"Nabekura","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jcyt.2018.11.001_bib0113","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood-2009-12-261487","article-title":"Elucidation of the integrin LFA-1-mediated signaling pathway of actin polarization in natural killer cells","volume":"116","author":"Mace","year":"2010","journal-title":"Blood"},{"issue":"7051","key":"10.1016\/j.jcyt.2018.11.001_bib0114","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jcyt.2018.11.001_bib0115","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2004-08-3156","article-title":"A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules","volume":"105","author":"Fernandez","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2018.11.001_bib0116","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jcyt.2018.11.001_bib0117","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.it.2009.01.006","article-title":"NK cell education: not an on-off switch but a tunable rheostat","volume":"30","author":"Brodin","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0118","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.4049\/jimmunol.1101640","article-title":"Leukemic priming of resting NK cells is KIR independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors","volume":"187","author":"Sabry","year":"2011","journal-title":"J.Immunol"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0119","article-title":"Highly cytotoxic CD56+CD8+ NK cells as potential novel candidates for cancer cellular therapy","volume":"13","author":"Suck","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2567.2005.02235.x","article-title":"Ligation of CD8\u03b1+ve on human Natural Killer cells prevents activation-induced apoptosis and enhances cytolytic activity","volume":"116","author":"Addison","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0121","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1078\/0171-2985-00219","article-title":"Functional significance of the activation-associated receptors CD25 and CD69 on human NK cells and NK-like T cell","volume":"207","author":"Clausen","year":"2003","journal-title":"Immunobiology"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0122","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2009-11-253286","article-title":"CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells","volume":"116","author":"Juelke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2018.11.001_bib0123","doi-asserted-by":"crossref","first-page":"17858","DOI":"10.1073\/pnas.0903474106","article-title":"The interation of TIGIT with PVR and PVRL2 inhibits NK cell cytoxicity","volume":"106","author":"Stanietsky","year":"2009","journal-title":"Proc Nat Acad Sci"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918306686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918306686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:38:18Z","timestamp":1761442698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324918306686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1465324918306686"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.11.001","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of human natural killer cells for therapeutic use","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}